Andrew Ekdahl, president of Johnson & Johnson’s DePuy Orthopaedics division, has testified that the company recalled its ASR hip implants because they weren’t meeting “clinical expectations,” and not because the company believed they had an underlying design defect.
But lawyers in a Chicago trial over injuries allegedly caused by the devices have produced a document that appears to contradict Ekdahl’s statement.
A Bloomberg story references a document from the Health Hazard/Risk Evaluation ...
continue reading...